Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2020-04-06 05:49:13| Fool.com Headlines

The biotech has manufactured enough doses to treat over 140,000 patients infected with the new coronavirus and is looking to further ramp up production.

Tags with treated patients gilead

Category: Investing

 

Latest from this category

16.04Stocks Slightly Lower into Close on Surging Long-Term Rates, Less Dovish Fed Commentary, Mid-East Regional War Fears, Financial/Homebuilding Sector Weakness
16.04Bear Radar
16.04Bull Radar
16.04Tomorrow's Earnings/Economic Releases of Note; Market Movers
16.04Mid-Day Market Internals
16.04Insights from the AI #WISA
16.04Unlocking Profitable Range Breaks with Trade Ideas NR7 Alerts
16.04Tuesday Watch
Investing »

All news

16.04Stocks Slightly Lower into Close on Surging Long-Term Rates, Less Dovish Fed Commentary, Mid-East Regional War Fears, Financial/Homebuilding Sector Weakness
16.04NASA confirms its space trash pierced Florida mans roof
16.04Mid-Day Market Internals
16.04Tomorrow's Earnings/Economic Releases of Note; Market Movers
16.04Bull Radar
16.04Bear Radar
16.04Potential new orders for struggling train firm
16.04Boston Dynamics sends Atlas to the robot retirement home
More »
Privacy policy . Copyright . Contact form .